These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1704309)

  • 1. Effect of gamma-butyrolactone on the retrograde axonal transport of neurotensin in dopaminergic neurones.
    Castel MN; Boireau A; Laduron PM
    Eur J Pharmacol; 1990 Sep; 186(1):133-6. PubMed ID: 1704309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrograde axonal transport of neurotensin in the dopaminergic nigrostriatal pathway in the rat.
    Castel MN; Malgouris C; Blanchard JC; Laduron PM
    Neuroscience; 1990; 36(2):425-30. PubMed ID: 1699166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system.
    Steinberg R; Bougault I; Souilhac J; Gully D; Le Fur G; Soubrié P
    Neurosci Lett; 1994 Jan; 166(1):106-8. PubMed ID: 7514773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of the amount of neurotensin retrogradely transported in dopaminergic neurons of senescent rats.
    Castel MN; Lechardeur D; Blanchard JC; Laduron PM
    Neurosci Lett; 1991 Mar; 124(1):111-4. PubMed ID: 1713313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neurons.
    Castel MN; Faucher D; Cuiné F; Dubédat P; Boireau A; Laduron PM
    J Neurochem; 1991 May; 56(5):1816-8. PubMed ID: 2013766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrograde axonal transport of neurotensin in rat nigrostriatal dopaminergic neurons. Modulation during ageing and possible physiological role.
    Castel MN; Beaudet A; Laduron PM
    Biochem Pharmacol; 1994 Jan; 47(1):53-62. PubMed ID: 7906122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light and electron microscopic localization of retrogradely transported neurotensin in rat nigrostriatal dopaminergic neurons.
    Castel MN; Woulfe J; Wang X; Laduron PM; Beaudet A
    Neuroscience; 1992 Sep; 50(2):269-82. PubMed ID: 1279459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrograde axonal transport of neurotensin in rat dopaminergic neurons.
    Castel MN; Faucher D; Malgouris C; Cuine F; Laduron PM
    Ann N Y Acad Sci; 1992; 668():320-2. PubMed ID: 1463275
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrograde axonal transport of neurotensin in the rat brain.
    Castel MN; Malgouris C; Blanchard JC; Laduron PM
    Eur J Pharmacol; 1989 Jul; 166(2):353-4. PubMed ID: 2792200
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transport.
    Burgevin MC; Castel MN; Quarteronet D; Chevet T; Laduron PM
    Neuroscience; 1992 Aug; 49(3):627-33. PubMed ID: 1354339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitter metabolism in substantia nigra after inhibition of dopaminergic neurones by butyrolactone.
    Hefti F; Lienhart R; Lichtensteiger W
    Nature; 1976 Sep; 263(5575):341-3. PubMed ID: 958491
    [No Abstract]   [Full Text] [Related]  

  • 15. Axonal and dendritic transport of internalized neurotensin in rat mesostriatal dopaminergic neurons.
    Faure MP; Nouel D; Beaudet A
    Neuroscience; 1995 Sep; 68(2):519-29. PubMed ID: 7477962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of morphine on dopamine metabolism in rat striatum and limbic structures in relation to the activity of dopaminergic neurones.
    Moleman P; van Valkenburg CF; vd Krogt JA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):208-13. PubMed ID: 6493361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc transport from the striatum and substantia nigra.
    Takeda A; Kodama Y; Ohnuma M; Okada S
    Brain Res Bull; 1998 Sep; 47(1):103-6. PubMed ID: 9766396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A; Rakovska A; Görcs T; Vizi ES
    Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.